Company profile
INTEGRATED BIOPHARMA INC CIK 1016504
Ticker
INBP (OTC)
Industry
Pharmaceutical Preparations
Headquarters
Hillside, NJ 07205
Fiscal year end
2026 (FY)
Key Financials
Revenue
—
Net income
-$2.84M
Total assets
$25.34M
Total liabilities
$7.67M
Stockholders' equity
$17.67M
Cash & equivalents
$4.47M
Operating income
-$2.71M
Operating cash flow
$1.24M
Capital expenditures
$346.0K
Fiscal year 2026, via 10-K filed 2026-09-25. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
$895.0K
Free cash flow margin
—
Liabilities / assets
30.3%
Equity / assets
69.7%
CapEx / revenue
—
Operating cash flow / net income
-0.44×
Derived from the fiscal year 2026 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2026
—
-$2.84M
$25.34M
$7.67M
$17.67M
2025
—
$808.0K
$24.90M
$4.58M
$20.32M
2024
—
$112.0K
$26.21M
$6.97M
$19.24M
2023
—
-$34.0K
$25.43M
$6.57M
$18.86M
2022
—
$3.84M
$25.25M
$6.68M
$18.58M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-08-20
Financials filed via
Form 10-K
filed 2026-09-25
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Hillside, NJ 07205
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:39 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.